Patents by Inventor Eng Huan Ung

Eng Huan Ung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIMICROBIAL FUSION COMPOUNDS AND USES THEREOF
    Publication number: 20160068829
    Abstract: A fusion protein comprising at least one Type 1 Ribosome Inactivating Protein, polypeptide B; and at least one polypeptide A capable of viral entry inhibition; and/or at least one Cationic AntiMicrobial Peptide, polypeptide C.
    Type: Application
    Filed: September 3, 2015
    Publication date: March 10, 2016
    Inventors: Muhammad Sagaf ABU BAKAR, Ag., Eng Huan UNG
  • Antimicrobial fusion compounds and uses thereof
    Patent number: 9155800
    Abstract: A fusion protein comprising at least one Type 1 Ribosome Inactivating Protein, polypeptide B; and at least one polypeptide A capable of viral entry inhibition; and/or at least one Cationic AntiMicrobial Peptide, polypeptide C.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: October 13, 2015
    Assignee: VALIANT BIOPHARMA SDN BHD
    Inventors: Muhammad Sagaf Abu Bakar, Ag., Eng Huan Ung
  • DOSAGE REGIME OF FUSION COMPOUNDS
    Publication number: 20150284438
    Abstract: Use of at least one fusion protein comprising at least one Type 1 Ribosome Inactivating Protein, polypeptide B; and at least one polypeptide A which is a antimicrobial peptide and/or at least one Cationic AntiMicrobial Peptide, polypeptide C for the preparation of a medicament for treating a cancer and/or a microbial infection wherein the medicament is suitable for oral administration pre food intake.
    Type: Application
    Filed: June 25, 2013
    Publication date: October 8, 2015
    Applicant: BioValence Sdn. Bhd.
    Inventors: Shamala Devi K C Sekaran, Hussin A. Rothan, Eng Huan Ung, Ag. Muhammad Sagaf Abu Bakar
  • ANTICANCER TREATMENT
    Publication number: 20150202250
    Abstract: Use of fusion protein comprising at least one polypeptide B, comprising Type 1 Ribosome Inactivating Protein, and at least one C having anticancer properties in the manufacture of a medicament for treating cancer in a subject in need thereof.
    Type: Application
    Filed: June 25, 2013
    Publication date: July 23, 2015
    Inventors: Shamala Devi K C Sekaran, Hussin A. Rothan, Eng Huan Ung, Muhammad Sagaf Abu Bakar, Ag.
  • RAPID SPECIFIC PATHOGEN FREE ANIMAL
    Publication number: 20150173333
    Abstract: A method of producing at least one specific pathogen free (SPF) non-human animal and/or a method of producing at least one specific pathogen resistant (SPR) non-human animal, the method comprising administration of a fusion protein to the surviving animal wherein the fusion protein comprises at least one polypeptide B which is a Type 1 Ribosome Inactivating Protein (RIP) or fragment thereof; and (i) at least one polypeptide A which is an Antimicrobial peptide; and/or (ii) at least one polypeptide C which is a Cationic Antimicrobial Peptide (CAP) or fragment thereof.
    Type: Application
    Filed: June 25, 2013
    Publication date: June 25, 2015
    Applicant: BIOVALENCE SDN. BHD.
    Inventors: Eng Huan Ung, Ag., Muhammad Sagaf Abu Bakar
  • ANTIMICROBIAL FUSION COMPOUNDS AND USES THEREOF
    Publication number: 20130336955
    Abstract: A fusion protein comprising at least one Type 1 Ribosome Inactivating Protein, polypeptide B; and at least one polypeptide A capable of viral entry inhibition; and/or at least one Cationic AntiMicrobial Peptide, polypeptide C.
    Type: Application
    Filed: January 9, 2012
    Publication date: December 19, 2013
    Applicant: VALIANT BIOPHARMA SDN BHD
    Inventors: Muhammad Sagaf Abu Bakar, Ag., Eng Huan Ung